Speaker: Wei-Zhi Hsu Advisor : Jun-Yi Yang 2017/05/02

Slides:



Advertisements
Similar presentations
Immune Activation/Inflammation and HIV Disease Prof. Georg Behrens Department for Clinical Immunology and Rheumatology Hannover Medical School Germany.
Advertisements

The FATZO mouse as a Translational Model for the Development of Drugs for Obesity, Metabolic Syndrome and Diabetes. PreClinOmics, Inc. 1.
Venkata J. Adapala, Sunday A. Adedokun, Robert V. Considine, Kolapo M
What’s All the Fuss About the Microbiome?
Chun-Ching Shih, Cheng-Hsiu Lin, Wei-Li Lin 
Gut Microbiota and Obesity
Role of thyroid hormone homeostasis in obesity-prone and obesity-resistant mice fed a high-fat diet  Shu-Fang Xia, Xiao-Mei Duan, Li-Yue Hao, Li-Ting.
Fig. 1. Body growth and leptin responsivity in young CPO and CTR mice
Peter L. Lee, Yuefeng Tang, Huawei Li, David A. Guertin 
Volume 4, Issue 12, Pages (December 2015)
Go Woon Kim, Hee Kyung Jo, Sung Hyun Chung  Journal of Ginseng Research 
The Alterations on Gut Microbiota and its Effects on Obesity
Intermyocellular fat depot
Won Hee Choi, Jiyun Ahn, Chang Hwa Jung, Jung Sook Seo, Tae Youl Ha 
Volume 20, Issue 3, Pages (July 2017)
Volume 66, Issue 4, Pages (April 2017)
Nat. Rev. Endocrinol. doi: /nrendo
Won Hee Choi, Jiyun Ahn, Chang Hwa Jung, Jung Sook Seo, Tae Youl Ha 
NAFLD, Obesity, and Bariatric Surgery
Volume 8, Issue 4, Pages (October 2008)
Figure 3 Polysaccharides from plants and mushrooms
David R. Meldrum, M. D. , Marge A. Morris, M. Ed. , R. D. , C. D. E
Volume 38, Issue 6, Pages (June 2013)
NAFLD: A multisystem disease
Volume 137, Issue 4, Pages e5 (October 2009)
Volume 138, Issue 7, Pages e1 (June 2010)
Ludger Scheja, Joerg Heeren  Journal of Hepatology 
Grzegorz Sumara, Olga Sumara, Jason K. Kim, Gerard Karsenty 
Volume 155, Issue 2, Pages (August 2018)
Volume 22, Issue 1, Pages (July 2015)
Volume 140, Issue 2, Pages (January 2010)
The Intestinal Immune System in Obesity and Insulin Resistance
Volume 18, Issue 2, Pages (August 2013)
Volume 22, Issue 3, Pages (March 2015)
Nat. Rev. Endocrinol. doi: /nrendo
Figure 1 Key mechanistic pathways involved in the gut–liver axis in NAFLD progression Figure 1 | Key mechanistic pathways involved in the gut–liver axis.
Volume 10, Issue 5, Pages (November 2009)
Iontophoresis and Sonophoresis Stimulate Epidermal Cytokine Expression at Energies That Do Not Provoke a Barrier Abnormality: Lamellar Body Secretion.
Pathways in Microbe-Induced Obesity
The Origins and Drivers of Insulin Resistance
IKKɛ: A Bridge between Obesity and Inflammation
Volume 134, Issue 4, Pages (April 2008)
Volume 18, Issue 10, Pages (March 2017)
High Glycemic Index Metabolic Damage – a Pivotal Role of GIP and GLP-1
Bridging immunity and lipid metabolism by gut microbiota
Chengcheng Jin, Jorge Henao-Mejia, Richard A. Flavell  Cell Metabolism 
Volume 37, Issue 3, Pages (September 2012)
Volume 20, Issue 13, Pages (September 2017)
Protection against High-Fat-Diet-Induced Obesity in MDM2C305F Mice Due to Reduced p53 Activity and Enhanced Energy Expenditure  Shijie Liu, Tae-Hyung.
David R. Meldrum, M. D. , Marge A. Morris, M. Ed. , R. D. , C. D. E
Innate sensors of pathogen and stress: Linking inflammation to obesity
Cold-Inducible SIRT6 Regulates Thermogenesis of Brown and Beige Fat
Volume 23, Issue 1, Pages e4 (January 2018)
Inflammation and Lipid Signaling in the Etiology of Insulin Resistance
Volume 3, Issue 2, Pages (February 2006)
Volume 20, Issue 1, Pages (July 2014)
Volume 17, Issue 8, Pages (November 2016)
Volume 10, Issue 1, Pages (July 2009)
Volume 1, Issue 4, Pages (April 2005)
Subhra K. Biswas, Raffaella Bonecchi  Cell Metabolism 
Volume 16, Issue 3, Pages (July 2016)
Volume 8, Issue 5, Pages (November 2008)
Blazej Zbytek, Andrzej T. Slominski 
Mimic treatment induces eWAT inflammation and hepatic steatosis.
Volume 24, Issue 12, Pages (September 2018)
Volume 7, Issue 4, Pages (May 2014)
MϕRIP140KD mice exhibit improved metabolic phenotypes.
Sander Lefere, Frank Tacke  JHEP Reports 
Fig. 4 Effects of hematopoietic restoration of TLR9 on adipose tissue inflammation and insulin resistance. Effects of hematopoietic restoration of TLR9.
Volume 18, Issue 3, Pages (January 2017)
Presentation transcript:

Speaker: Wei-Zhi Hsu Advisor : Jun-Yi Yang 2017/05/02 Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota Speaker: Wei-Zhi Hsu Advisor : Jun-Yi Yang 2017/05/02

low-grade inflammation Obesity Insulin resistance type 2 diabetes… Obesity-associated low-grade inflammation Composition of the gut microbiota are associated with the development of obesity and its associated metabolic disorders. (Science 341, 1241214 (2013)) Obesity-induced gut dysbiosis caused by either environmental or genetic factors impairs intestinal integrity.(Gut 58, 1091–1103 (2009))

Gut microbiota The endotoxin lipopolysaccharide (LPS) from intestinal Gram-negative bacteria get into the bloodstream, leading to metabolic inflammation and insulin resistance (Invest. 115, 1111–1119 (2005).)

Obesity Pro-inflammation LPS : Lipopolysaccharide LBP : Lipobinding protein Journal of Molecular Endocrinology 51:2 ,R51–R64, 2013

Obesity Pro-inflammation, insulin resistance November 2015 | Volume 6 | Article 341

Previous study Triterpenes and polysaccharides isolated from G. lucidum inhibit adipocyte differentiation and produce hypoglycaemia effects in diabetic mice. Proteoglycans isolated from G. lucidum fruiting bodies induce antidiabetic, antihyperlipidemic and antioxidant activities.

Pro-inflammation cytokines Aim How G. lucidum produces any effect on body weight and obesity-related disorders? Obesity Insulin resistance Imflammation Intestinal integrity Pro-inflammation cytokines Gut microbiota Endotoximia (LPS) TLR4 Insulin resistance

Pro-inflammation cytokines Obesity Insulin resistance Imflammation Intestinal integrity Pro-inflammation cytokines Gut microbiota Endotoximia (LPS) TLR4

Water extract of G. lucidum mycelium (WEGL) 400 g of dried G. lucidum mycelium / 10 L water agitation at 150 r.p.m. for 30 min at 121 °C cooled to room temperature (22 °C) centrifugation at 5,894g for 30 min at 4 °C The supernatant was concentrated at 65 °C to obtain a final volume of 2 L.

WEGL prevents HFD-induced obesity in mice mice fed for 2 months chow diet HFD 100 ml water or WEGL at 2, 4 or 8% (Everyday) standard chow diet : 13.5% of energy from fat high-fat diet ( HFD ) : 60% of energy from fat

WEGL prevents HFD-induced obesity in mice

Adipose size and liver lipid content oil red O staining : lipid Dye WEGL prevent HFD-induce obesity and decrease adipose size and liver lipid content

Pro-inflammation cytokines Obesity Insulin resistance Imflammation Intestinal integrity Pro-inflammation cytokines Gut microbiota Endotoximia (LPS) TLR4

Detect inflammation gene in HFD-fed mice with WEGL Pro-inflammatory cytokines Anti-inflammatory cytokines TNF-α, IL-1β, IL-6, PAI-1 IL-10 Measure messenger RNA of hepatic and adipose

Pro-inflammatory cytokines

Anti-inflammatory cytokines WEGL reduces inflammation gene expression in HFD-fed mice

Pro-inflammation cytokines Obesity Insulin resistance Imflammation Intestinal integrity Pro-inflammation cytokines Gut microbiota Endotoximia (LPS) TLR4

WEGL reduce serum endotoximia

Pro-inflammation cytokines TLR4 JNK IKK-β IKB- α phopholation NFk-β Pro-inflammation cytokines

WEGL reduces endotoxemia and insulin resistance in HFD mice

Pro-inflammation cytokines Obesity Insulin resistance Imflammation Intestinal integrity Pro-inflammation cytokines Gut microbiota Endotoximia (LPS) TLR4

Classification of mice with WEGL or not

WEGL alters gut microbiota composition in HFD-fed mice

WEGL faecal transplants reduce obesity transferred the microbiota of WEGL-treated mice to HFD-fed mice Chow->HFD HFD->HFD Chow+8% WEGL ->HFD HFD+8% WEGL ->HFD

Compare with different organ weight Obesity and fat accumulation are reversed by faecal transplantation from WEGL-treated mice to HFD-fed mice

Analysis pro-inflammatory cytokines following faecal transplantation from WEGL-treated mice

Gut microbiota influence intestinal integrity in HFD mice Gut microbiota decrease tight-junction protein in HFD mice

Analysis of gut microbiota following faecal transplantation

Analysis of gut microbiota following faecal transplantation

Polysaccharides analysed from a WEGL

Effect of WEGL polysaccharide fractions on body weight and fat accumulation in HFD-fed mice

Summary Ganoderma lucidum can reduce obesity. Polysaccharide of WEGL play a important role of reduce obesity.